New Hampshire 2020 Regular Session Status: In Committee

HB 1610 — establishing the manufacturer pharmaceutical drug take-back program.

Last action — Interim Study Report: Not Recommended for Future Legislation (Vote 19-0)

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 1610 on the official New Hampshire source →

Action History

  1. Interim Study Report: Not Recommended for Future Legislation (Vote 19-0)

  2. Full Committee Work Session: 09/03/2020 02:00 pm Members of the public may attend using this link: https://www.zoom.us/j/93480617681 - Executive Session to Follow

  3. Refer for Interim Study: MA VV 03/11/2020 HJ 7 P. 34

  4. Committee Report: Refer for Interim Study for 03/11/2020 (Vote 20-0; CC) HC 10 P. 20

  5. Executive Session: 03/03/2020 10:00 am LOB 205

  6. Subcommittee Work Session: 02/18/2020 10:00 am LOB 205

  7. Public Hearing: 01/30/2020 10:45 am LOB 205

  8. Introduced 01/08/2020 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 28

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 407 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (407)

407 members have not signed on to this bill.

Show all 407 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 1610?
HB 1610 is sponsored by Martha Fuller Clark, Jeb Bradley, Rebecca McBeath, Tom Sherman, Tom J. Loughman, Gary Merchant, William L. Fowler, and Shannon E. Chandley.
What is the current status of HB 1610?
This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 1610?
Track HB 1610 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1610

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1610

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →